106 related articles for article (PubMed ID: 20388724)
21. Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran.
Tabarsi P; Nooraki A; Mirsaeidi M; Amiri M; Baghaei P; Farnia P; Kazempour M; Heidarnazhad H; Alipanah N; Mansouri D; Masjedi MR
Respirology; 2008 Jan; 13(1):108-11. PubMed ID: 18197919
[TBL] [Abstract][Full Text] [Related]
22. Multidrug-resistant tuberculous meningitis in children in Durban, South Africa.
Padayatchi N; Bamber S; Dawood H; Bobat R
Pediatr Infect Dis J; 2006 Feb; 25(2):147-50. PubMed ID: 16462292
[TBL] [Abstract][Full Text] [Related]
23. Treatment of multidrug-resistant tuberculosis: evidence and controversies.
Caminero JA; ; ;
Int J Tuberc Lung Dis; 2006 Aug; 10(8):829-37. PubMed ID: 16898365
[TBL] [Abstract][Full Text] [Related]
24. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
Reechaipichitkul W
Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593
[TBL] [Abstract][Full Text] [Related]
25. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F
Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
[TBL] [Abstract][Full Text] [Related]
26. Extensively drug-resistant tuberculosis: new strains, new challenges.
Banerjee R; Schecter GF; Flood J; Porco TC
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
[TBL] [Abstract][Full Text] [Related]
27. Drug-resistant tuberculosis in Ethiopia: problem scenarios and recommendation.
Abate G
Ethiop Med J; 2002 Jan; 40(1):79-86. PubMed ID: 12240570
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis.
Rosales S; Pineda-García L; Andino N; Almendarez N; Membreño H; Hoffner SE
Int J Tuberc Lung Dis; 2009 Dec; 13(12):1542-9. PubMed ID: 19919774
[TBL] [Abstract][Full Text] [Related]
29. Management of multidrug-resistant tuberculosis: Update 2007.
Yew WW; Leung CC
Respirology; 2008 Jan; 13(1):21-46. PubMed ID: 18197909
[TBL] [Abstract][Full Text] [Related]
30. [Exogenous re-infection in tuberculosis].
Tsuchiya T
Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
[TBL] [Abstract][Full Text] [Related]
31. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
32. Surgical treatment for multidrug-resistant and extensive drug-resistant tuberculosis.
Kang MW; Kim HK; Choi YS; Kim K; Shim YM; Koh WJ; Kim J
Ann Thorac Surg; 2010 May; 89(5):1597-602. PubMed ID: 20417785
[TBL] [Abstract][Full Text] [Related]
33. Extensively drug-resistant tuberculosis: current challenges and threats.
Jain A; Mondal R
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439
[TBL] [Abstract][Full Text] [Related]
34. New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes.
Lienhardt C; Vernon A; Raviglione MC
Curr Opin Pulm Med; 2010 May; 16(3):186-93. PubMed ID: 20216421
[TBL] [Abstract][Full Text] [Related]
35. Promising candidates in clinical trials against multidrug-resistant tuberculosis (MDR-TB) based on natural products.
de Souza MV
Fitoterapia; 2009 Dec; 80(8):453-60. PubMed ID: 19698768
[TBL] [Abstract][Full Text] [Related]
36. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.
Ormerod LP
Br Med Bull; 2005; 73-74():17-24. PubMed ID: 15956357
[TBL] [Abstract][Full Text] [Related]
37. Management of multidrug-resistant tuberculosis in children: a survival guide for paediatricians.
Schaaf HS; Marais BJ
Paediatr Respir Rev; 2011 Mar; 12(1):31-8. PubMed ID: 21172673
[TBL] [Abstract][Full Text] [Related]
38. [Cross-resistance between rifampicin and rifabutin among multi-drug resistant Mycobacterium tuberculosis strains].
Chikamatsu K; Mizuno K; Yamada H; Mitarai S
Kekkaku; 2009 Sep; 84(9):631-3. PubMed ID: 19860266
[TBL] [Abstract][Full Text] [Related]
39. [Infectiousness and virulence of multidrug-resistant and drug susceptible tuberculosis in adult contacts].
Palmero D; Cusmano L; Bucci Z; Romano M; Ruano S; Waisman J
Medicina (B Aires); 2002; 62(3):221-5. PubMed ID: 12150003
[TBL] [Abstract][Full Text] [Related]
40. Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa.
Patel VB; Padayatchi N; Bhigjee AI; Allen J; Bhagwan B; Moodley AA; Mthiyane T
Clin Infect Dis; 2004 Mar; 38(6):851-6. PubMed ID: 14999630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
